LEESBURG, Va., Jan. 21, 2015 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (Nasdaq:KTWO) (the "Company" or "K2M"), a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the MESA® 2 Deformity Spinal System. MESA 2 is the Company's next-generation pedicle screw system designed to address the most complex spinal pathologies.
The MESA 2 Deformity Spinal System features the next-generation MESA 2 screw, a top-loading, low-profile screw that offers a dual-lead thread pattern for fast insertion. K2M's MESA Technology also features Zero-Torque Technology®, which offers surgeons the ability to one-step lock without torsional stress being applied to the spine. Both deformity polyaxial and uniplanar screws are available in this new system.
"I am excited about MESA 2," said Laurel C. Blakemore, MD, chief and associate professor of pediatric orthopaedics in the department of orthopaedics at the University of Florida. "Compared to its predecessor, MESA 2's dual-lead thread provides the opportunity for quicker screw insertion and the on/off button on the Crickets® provide an easier way for the Crickets to latch on to the MESA head to help save time during correction."
The MESA 2 instrumentation includes upgrades with increased efficiency in mind. For example, the new Quick Cricket®, the next generation of K2M's breakthrough Cricket rod reduction technology, provides quick on/off capabilities, while correcting the spine in all three planes. Additionally, the Over Cricket Final Locker allows for one-step locking over the Cricket, thus eliminating the need to partial lock.
"FDA clearance of MESA 2 is a milestone event for K2M that further enhances our position in the global complex spine surgery market," stated Eric Major, K2M's President and CEO. "The development of MESA 2 reflects K2M's continued commitment to developing innovative products and providing surgeons with tools that facilitate their management of the most challenging spinal conditions. MESA 2 carries forward the hallmarks of our MESA and Cricket rod reduction technologies, while offering new capabilities with the goal of enhancing user experience."
For more information on the MESA 2 Deformity Spinal System and K2M's complete product portfolio, visit www.K2M.com.
About K2M
K2M Group Holdings, Inc. is a global medical device company focused on designing, developing and commercializing innovative complex spine and minimally invasive spine technologies and techniques used by spine surgeons to treat some of the most difficult and challenging spinal pathologies. K2M has leveraged these core competencies to bring to market an increasing number of products for patients suffering from degenerative spinal conditions. These technologies and techniques, in combination with a robust product pipeline, enable the Company to favorably compete in the global spinal surgery market. Additional information is available online at www.K2M.com.
Forward-Looking Statements
Certain statements made in this press release may constitute "forward-looking statements" within the meaning of the federal securities laws. Forward-looking statements are based on management's expectations, estimates, projections, and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors. Additional information regarding these factors is contained in the Company's Registration Statement on Form S-1 filed with the SEC.
Find K2M on Facebook: https://www.facebook.com/K2MInc
Follow K2M on Twitter: http://twitter.com/K2MInc
Watch K2M on YouTube: http://www.youtube.com/user/K2MInc